Kalyoncu, U. Et Al. 2021. TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA. ANNALS OF THE RHEUMATIC DISEASES , vol.80 , 69-70.

Kalyoncu, U., Bilgin, E., Erden, A., Satis, H., Tufan, A., Tekgoz, E., ... Ates, A.(2021). TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA. ANNALS OF THE RHEUMATIC DISEASES , vol.80, 69-70.

Kalyoncu, U. Et Al. "TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA," ANNALS OF THE RHEUMATIC DISEASES , vol.80, 69-70, 2021

Kalyoncu, U. Et Al. "TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA." ANNALS OF THE RHEUMATIC DISEASES , vol.80, pp.69-70, 2021

Kalyoncu, U. Et Al. (2021) . "TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA." ANNALS OF THE RHEUMATIC DISEASES , vol.80, pp.69-70.

@article{article, author={U. Kalyoncu Et Al. }, title={TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2021, pages={69-70} }